America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Assessing the pros and cons of zero based budgeting can guide your financial planning. Discover what works best for your situation.
28,655 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Powell will continue to serve on the Federal Reserve Board after his chair term ends next month, steering a measured ...
A 50-year-old couple with $1.1 million in retirement savings faces 15 years of growth and withdrawals. With $50,000 s...
A 160-year naming split between soccer and football continues to ripple through branding, sponsorships, and consumer ...
CFOs are bullish about their own firms even as the broader economy slows, according to Deloitte's Q2 2026 CFO Signals...
As deposit wars heat up in 2026, this report weighs the real value of chasing checking account bonuses worth the effo...
Anthropic’s Fable returns to service as the U.S. eases export controls, but a cloudy policy framework keeps investors...
As Japan faces a shrinking workforce and aging digital infrastructure, devin-kun is emerging as a pivotal tool to mod...
The United States launched strikes on Iranian targets after an attack that killed U.S. troops in Jordan, while Tehran...
Satellogic’s 2026 earnings hinge on a mix of recurring data licenses, expanding contracts, and efficient scaling. Thi...
AST SpaceMobile has surged, leaving investors asking whether spacemobile buy, sell, hold makes sense now. This articl...
This guide breaks down APR, annual fees, and credit card fine print in plain language. Learn how these factors affect...